Premier Inc. announced two new deals yesterday, bringing them to four contracts this week alone.
The hospital group purchasing organization signed contracts with Deerfield, Ill.-based Siemens AG (NYSE:SI) and Instrumentation Laboratory of Bedford, Mass.
Earlier this week Premier signed contracts with both Covidien plc (NYSE:COV) and Medline Industries Inc. for incontinence products, and announced deals with six new companies last month.
Health Benefit Consultants, Share Your Expert Insights in Our Survey
MassDevice Staff Website The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.
Hospital GPOs have been vocal about signing contract recently, perhaps in response to Medtronic Inc.’s (NYSE:MDT) headline-making, Wall Street-pleasing decision to cut several contracts worth an estimated $2 billion a year for its cardiovascular and orthopedic products with Irving, Texas-based GPO Novation in February.
Novation touted 11 new deals across general radiology and molecular imaging equipment yesterday, affirming the continued GPO presence in the market.
“As demonstrated by these agreements, suppliers continue to find value in the Novation relationship,” Novation VP of contract and program services Michael Vintges said in a press release. “Suppliers find that participating in our contracts provides increased brand awareness and market share through access to the members we serve.”
Premier’s new deals are effective Oct. 1, according to a press release.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.
